CAAS Capital Management’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
SLG
ZCI
CAAS Capital Management's GDRX Position: Q1 2021 in Review
CAAS Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2021, closing a stake of 454,095 shares — an estimated $18.3M sold.
CAAS Capital Management first reported a position in GDRX in Q3 2020 and held it in 2 quarters. The position peaked at $25.2M in Q3 2020. 205 funds tracked by Wall St. Rank hold GDRX as of Q1 2021.
- CAAS Capital Management reported no remaining GoodRx Holdings position as of Q1 2021 after selling out during the quarter.
- CAAS Capital Management sold 454,095 GoodRx Holdings shares in Q1 2021, an estimated $18.3M.
- CAAS Capital Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 2 quarters.
- CAAS Capital Management's GoodRx Holdings position peaked at $25.2M in Q3 2020.
- 205 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2021.
Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.